Read + Share
Jabbour E, Sasaki K, Haddad FG, Issa GC, et al. The Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-line
BCR::ABL1 Tyrosine Kinase Inhibitors. Am J Hematol 2023 Jan 22. doi: 10.1002/ajh.26852.
PMID: 36683287
|
 |
|
Jabbour E, Sasaki K, Haddad FG, Issa GC, et al. The Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-line
BCR::ABL1 Tyrosine Kinase Inhibitors. Am J Hematol 2023 Jan 22. doi: 10.1002/ajh.26852.
PMID: 36683287
|
|
|
|